Company Filing History:
Years Active: 1997-1999
Title: Igor Solodin: Innovator in Amphiphilic Compounds
Introduction
Igor Solodin is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of biochemistry, particularly in the development of amphiphilic compounds. With a total of 5 patents to his name, Solodin's work has the potential to impact various applications in medicine and biotechnology.
Latest Patents
Among his latest patents, Solodin has developed cationic derivatives of biguanide, which are useful in the preparation of lipid carriers for mediating transfection of mammalian cells both in vivo and in vitro. Additionally, he has created novel, heterocyclic cationic amphiphiles that are designed to degrade in vivo. These compounds can produce liposomes that serve as carriers for delivering macromolecules intracellularly, with the capability of targeting specific cell types.
Career Highlights
Igor Solodin is currently associated with Megabios Corporation, where he continues to innovate and advance his research. His work is characterized by a strong focus on the practical applications of his inventions in the medical field.
Collaborations
Solodin collaborates with notable colleagues, including Timothy D Heath and Jinkang Wang, who contribute to his research endeavors and help enhance the impact of his inventions.
Conclusion
Igor Solodin's innovative work in amphiphilic compounds showcases his dedication to advancing biochemistry and biotechnology. His patents reflect a commitment to developing solutions that could transform medical applications.